AnchorDx, also known as 基准医疗, is a precision medicine company founded in 2015 in Guangzhou, China, with R&D centers in China and the USA. It focuses on methylation high‑throughput sequencing for early cancer detection, offering blood‑based and urine‑based tests covering over 70% of high‑incidence cancers. The company has filed 82 patents (32 granted) and serves more than 100,000 patients, integrating AI and big‑data platforms for diagnostics and monitoring.
AnchorDx is profiled on the APIs.io network. Tagged areas include Company, Precision Medicine, Cancer Detection, Genomics, and Artificial Intelligence.
Regulatory Posture applies to this provider. Its tags matched the
Horizontal (data, software, accessibility, platform) regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/anchordx: open an issue to ask a question, or submit a pull request to add artifacts.
Submit an artifact on GitHub — free →Manage your own listing — the Influence plan, $499/mo →
aid: anchordx
name: AnchorDx
description: AnchorDx, also known as 基准医疗, is a precision medicine company founded in 2015 in Guangzhou, China, with R&D centers
in China and the USA. It focuses on methylation high‑throughput sequencing for early cancer detection, offering blood‑based
and urine‑based tests covering over 70% of high‑incidence cancers. The company has filed 82 patents (32 granted) and serves
more than 100,000 patients, integrating AI and big‑data platforms for diagnostics and monitoring.
url: https://raw.githubusercontent.com/api-evangelist/anchordx/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment pass 2026-09-24 (modular-v1; was harvest)
specificationVersion: '0.20'
created: '2026-09-24'
modified: '2026-09-24'
tags:
- Company
- Precision Medicine
- Cancer Detection
- Genomics
- Artificial Intelligence
tags_raw:
- Company
- Precision Medicine
- Cancer Detection
- Genomics
- AI
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Hosts
url: hosts/anchordx-hosts.yml
- type: Vendors
url: vendors/anchordx-vendors.yml
- type: DomainSecurity
url: security/anchordx-domain-security.yml
- type: Website
url: https://forgeglobal.com/anchordx_stock/
apis: []
x-enrichment:
date: '2026-09-24'
status: enriched
artifacts_added: 3
pass: modular-v1
engine: identity=local,contract=local,surfaces=local,docs=local
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →